Quantcast

Latest Adalimumab Stories

2012-09-11 04:20:06

Tokyo, Sept 11, 2012 - (JCN Newswire) - Eisai Co., Ltd. announced today that it will launch the anti-rheumatic agent Careram(R) (iguratimod) in Japan on September 12 for the treatment of rheumatoid arthritis. Careram, jointly developed in Japan by Eisai and Toyama Chemical Co., Ltd. from the Phase III clinical development stage, was approved by Japan's Ministry of Health, Labour and Welfare (MHLW) in June of this year and was subsequently listed on the National Health Insurance Drug Price...

Drug Gets Green Light To Treat Ulcerative Colitis
2012-08-29 16:29:05

Lee Rannals for redOrbit.com — Your Universe Online People suffering from ulcerative colitis may be getting some new relief due to a decision by the Food and Drug Administration (FDA) to expand the use of a new drug to help alleviate symptoms. An FDA panel voted 15 to 2 that the benefits of Humira outweighed the risks it causes when treating the condition. Humira is already approved to be used for six other conditions, and is most popular for its use to help in rheumatoid...

2012-08-08 22:21:16

Study compares overall mortality in TNF inhibitors: Humira, Enbrel, and Remicade New research confirms no significant difference in the rates of death among patients with rheumatoid arthritis (RA) who were exposed to one of several TNF inhibitors used to treat RA, adalimumab (Humira), etanercept (Enbrel), and infliximab (Remicade). This population-based study of RA patients in Sweden–the first to compare mortality rates among patients treated with individual TNF inhibitors–is...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.